Godavari Biorefineries Q2 Results: Net Loss Increases to ₹75 Crore in Q2
Colgate Palmolive Q1 Results FY2023, PAT at Rs. 209.67 crores
Last Updated: 10th December 2022 - 12:35 pm
On 27th July 2022, Colgate Palmolive announced its quarterly results for the first quarter of FY2023.
Q1FY23 Key Highlights:
- The company reported its net sales at Rs. 1186.59 crores with a growth of 2.48 % YoY.
- Profit before tax was reported at Rs. 282.41 crores with a drop of 10.11% YoY.
- The company reported its PAT at Rs. 209.67 crores with a drop of 10.10% YoY.
Commenting on the results, Mr. Mukul Deoras, Chairman at Colgate-Palmolive (India) Limited, said, “The current quarter continued to witness challenging trends that we saw in the previous quarter. While we remain cautiously optimistic that the trends will improve in the coming quarters, the current quarter was impacted by overall rural slowdown and inflationary pressures. Our overall pricing strategy and strong funding for the growth programs delivered consistent margins while we continue to maintain our strong investment in innovation and brand-building activities.
Our recent launch of Visible White O2 with patented innovative technology has been very well appreciated by consumers. Also, our new category launches such as the Palmolive Face care range and extensions in the oral care segment with Advanced Electric Toothbrushes and Water Flossers have recorded encouraging responses. Moreover, our relaunches of Colgate Strong Teeth and Colgate Vedshakti toothpaste have also been very well received, reinforcing our commitment to bring to market superior products that enhance consumer experiences.
As an organization, we continue to live our values and remain unwavering in our focus to improve the health and well-being of our consumers and deliver long-term shareholder value.”
Trending on 5paisa
03
5paisa Research Team
Discover more of what matters to you.
Corporate Actions Related Articles
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.